Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian Murtagh

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
JCI Insight|September 30, 2025
Characterization of anticancer therapy-induced microvascular dysfunction in patients with breast cancer supports targeted interventionJanée D Terwoord, Laura E Norwood Toro, Shelby N Hader, et al.
Echocardiography (Mount Kisco, N.Y.)|September 29, 2016
Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fractionGillian Murtagh, Luke J Laffin, Kershaw V Patel, et al.
Cardio-Oncology (London, England)|November 28, 2024
A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2)Fei Fei Gong, Eli Grunblatt, Woo Bin Voss, et al.
Journal of the American Heart Association|November 6, 2023
High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion RevascularizationDaniel A Gold, Pratik B Sandesara, Vardhmaan Jain, et al.
The American Journal of Cardiology|September 17, 2020
Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery DiseaseBruno B Lima, Muhammad Hammadah, Jeong Hwan Kim, et al.
International Journal of Cardiology|May 23, 2024
N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularizationDaniel A Gold, Pratik B Sandesara, Vardhmaan Jain, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
The American Journal of Cardiology|April 10, 2018
Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney DiseasePratik B Sandesara, Wesley T O'Neal, Ayman Samman Tahhan, et al.
Journal of the American Heart Association|February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesAyman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Journal of Cardiac Failure|April 4, 2016
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary SpecialtyDaniel J Lenihan, Gregory Hartlage, Jeanne DeCara, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
JCI Insight|September 30, 2025
Characterization of anticancer therapy-induced microvascular dysfunction in patients with breast cancer supports targeted interventionJanée D Terwoord, Laura E Norwood Toro, Shelby N Hader, et al.
Echocardiography (Mount Kisco, N.Y.)|September 29, 2016
Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fractionGillian Murtagh, Luke J Laffin, Kershaw V Patel, et al.
Cardio-Oncology (London, England)|November 28, 2024
A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2)Fei Fei Gong, Eli Grunblatt, Woo Bin Voss, et al.
Journal of the American Heart Association|November 6, 2023
High Sensitivity Troponin Level and Benefits of Chronic Total Occlusion RevascularizationDaniel A Gold, Pratik B Sandesara, Vardhmaan Jain, et al.
The American Journal of Cardiology|September 17, 2020
Relation of High-sensitivity Cardiac Troponin I Elevation With Exercise to Major Adverse Cardiovascular Events in Patients With Coronary Artery DiseaseBruno B Lima, Muhammad Hammadah, Jeong Hwan Kim, et al.
International Journal of Cardiology|May 23, 2024
N terminal pro-brain natriuretic peptide level and benefits of chronic total occlusion revascularizationDaniel A Gold, Pratik B Sandesara, Vardhmaan Jain, et al.
The American Journal of Cardiology|July 30, 2023
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery DiseaseShivang R Desai, Devinder S Dhindsa, Yi-An Ko, et al.
The American Journal of Cardiology|April 10, 2018
Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney DiseasePratik B Sandesara, Wesley T O'Neal, Ayman Samman Tahhan, et al.
Journal of the American Heart Association|February 23, 2018
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term OutcomesAyman Samman Tahhan, Pratik Sandesara, Salim S Hayek, et al.
Journal of Cardiac Failure|April 4, 2016
Cardio-Oncology Training: A Proposal From the International Cardioncology Society and Canadian Cardiac Oncology Network for a New Multidisciplinary SpecialtyDaniel J Lenihan, Gregory Hartlage, Jeanne DeCara, et al.
Pageof 5